Obesity Is an Independent Prognostic Factor That Reduced Pathological Complete Response in Operable Breast Cancer Patients

<i>Background and Objectives</i>: Obesity is a significant risk factor for the development of breast cancer (BC) and associated poorer outcomes. A pathological complete response (pCR) with neoadjuvant chemotherapy (NACT) correlates with improved long-term prognosis in BC patients. In this study, we aimed to investigate the predictive effect of obesity on achieving pCR following NACT. <i>Methods</i>: This single-center retrospective study included patients with operable BC who were treated with NACT. Patients were categorized based on their pre-chemotherapy body mass index (BMI), including non-obese (<30 kg/m<sup>2</sup>) and obese (≥30 kg/m<sup>2</sup>) groups, and pathological responses to NACT were compared. <i>Results</i>: A total of 191 female patients were included in this study; of these, 83 (43.4%) were obese and 108 (56.6%) were in the non-obese group. Obesity was more common in postmenopausal patients, and the median age of obese patients was significantly higher compared to non-obese patients. Patients in the obese group demonstrated significantly lower pCR rates compared to the non-obese group (30% vs. 45%, <i>p</i> = 0.03). The histological subtype assessment indicated that only in the HR-positive/HER2-negative patients was the pCR rate significantly lower in the obese group compared to the non-obese group (11% vs. 27%, <i>p</i> = 0.05). According to menopausal assessment, a significant difference in pCR rates was observed only among postmenopausal patients, with rates of 29% in the obese group compared to 52% in the non-obese group (<i>p</i> = 0.03). In logistic regression analysis, obesity (OR: 0.52, 95% CI: 0.28-0.97; <i>p</i> = 0.04) and a low Ki-67 score (HR: 2.7, 95% CI: 1.37-5.53; <i>p</i> = 0.003) were independently associated with a decreased rate of pCR. <i>Conclusions</i>: The impact of obesity on achieving pCR in BC patients undergoing NACT remains controversial. Our study revealed that obesity was an independently significant negative predictive factor for achieving pCR.

Authors

Institutions

Publication Details

Journal
Medicina
Published
2024-11-27
DOI
https://doi.org/10.3390/medicina60121953
Citations
5
Primary Topic
Cancer Risks and Factors
Type
article
Field-Weighted Citation Impact
1.41
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Obesity Is an Independent Prognostic Factor That Reduced Pathological Complete Response in Operable Breast Cancer Patients

Murat Günaltılı, Özkan Alan, Ezgi Değerli, Çiğdem Papila et al.
5 citations
Medicina
Cancer Risks and Factors
1.41
article

Obesity Is an Independent Prognostic Factor That Reduced Pathological Complete Response in Operable Breast Cancer Patients

Murat Günaltılı, Özkan Alan, Ezgi Değerli, Çiğdem Papila, G. Sen, Berrin Papila Kundaktepe, Murad Guliyev, Shamkhal Safarov, Nebi Serkan Demirci, Mehmet Cem Fidan
article en
5 citations

Abstract

<i>Background and Objectives</i>: Obesity is a significant risk factor for the development of breast cancer (BC) and associated poorer outcomes. A pathological complete response (pCR) with neoadjuvant chemotherapy (NACT) correlates with improved long-term prognosis in BC patients. In this study, we aimed to investigate the predictive effect of obesity on achieving pCR following NACT. <i>Methods</i>: This single-center retrospective study included patients with operable BC who were treated with NACT. Patients were categorized based on their pre-chemotherapy body mass index (BMI), including non-obese (<30 kg/m<sup>2</sup>) and obese (≥30 kg/m<sup>2</sup>) groups, and pathological responses to NACT were compared. <i>Results</i>: A total of 191 female patients were included in this study; of these, 83 (43.4%) were obese and 108 (56.6%) were in the non-obese group. Obesity was more common in postmenopausal patients, and the median age of obese patients was significantly higher compared to non-obese patients. Patients in the obese group demonstrated significantly lower pCR rates compared to the non-obese group (30% vs. 45%, <i>p</i> = 0.03). The histological subtype assessment indicated that only in the HR-positive/HER2-negative patients was the pCR rate significantly lower in the obese group compared to the non-obese group (11% vs. 27%, <i>p</i> = 0.05). According to menopausal assessment, a significant difference in pCR rates was observed only among postmenopausal patients, with rates of 29% in the obese group compared to 52% in the non-obese group (<i>p</i> = 0.03). In logistic regression analysis, obesity (OR: 0.52, 95% CI: 0.28-0.97; <i>p</i> = 0.04) and a low Ki-67 score (HR: 2.7, 95% CI: 1.37-5.53; <i>p</i> = 0.003) were independently associated with a decreased rate of pCR. <i>Conclusions</i>: The impact of obesity on achieving pCR in BC patients undergoing NACT remains controversial. Our study revealed that obesity was an independently significant negative predictive factor for achieving pCR.

MedicinaVol. 60(12)
Istanbul University-Cerrahpaşa (TR)
No poverty
Openalex Percentile: Top 15%
Cancer Risks and Factors
1.41
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.